Today's Information

Provided by: EirGenix Inc.
SEQ_NO 3 Date of announcement 2022/08/11 Time of announcement 18:10:14
Subject
 Announcement of the Construction Design
and Consulting Fee for New Plant.
Date of events 2022/08/11 To which item it meets paragraph 20
Statement
1.Type of contract:Construction Design and Consulting Fee.
2.Date of occurrence of the event:2022/08/11
3.Counterparty to the contract and relationship with
the Company:
  Facility construction design companies and consultant companies.
  Relationship with the Company: None.
4.Major content of the contract (including total contract
amount, anticipated monetary amount of participation in the
investment, and start and end dates of the contract),
restrictive covenants, and other important terms and
conditions:
  Total contract amount:
   The upper limit is NT$0.45 billion
   (tax and exchange difference included)
  Start and end dates of the contract:
   From the signing date to the completion date of the new plant
   construction design.
  Restrictive covenants: None.
  Other important terms and conditions: None.
5.Name of the professional appraisal firm or company and
its appraisal opinion:N/A
6.Name of the real property appraiser:N/A
7.Practice certificate number of the real property appraiser:N/A
8.Concrete purpose of the acquisition:
  To prepare for the growth of the CDMO business
  and the commercial needs of internal development products,
  the company plans to build up a large-scale
  mammalian cell culture facility of 150,000L
  split into three stages within 6 to 8 years' time.
9.Any dissenting opinions of directors to the present
transaction:None.
10.Whether the counterparty of the current transaction is
a related party:No.
11.Date of the board of directors' resolution:2022/08/11
12.Date of ratification by supervisors or approval by the
 audit committee:2022/08/11
13.The appraisal report has a limited price, specific price,
or special price:NA
14.An appraisal report has not yet been obtained:NA
15.Reason for an appraisal report not being obtained:N/A
16.Reason for any significant discrepancy with the appraisal
reports and opinion of the CPA:N/A
17.Name of the CPA firm:N/A
18.Name of the CPA:N/A
19.Practice certificate number of the CPA:N/A
20.29.Any other matters that need to be specified:None.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

EirGenix Inc. published this content on 11 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 August 2022 10:23:04 UTC.